Metastatic basal cell carcinoma: report of two cases treated with cetuximab.
Caron
J
J
Dereure
O
O
Kerob
D
D
Lebbe
C
C
Guillot
B
B
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001365:Axilla; D002280:Basal Cell Carcinoma / Q000188:drug therapy* / Q000556:secondary; D000068818:Cetuximab; D017809:Fatal Outcome; D006679:HIV Seropositivity / Q000150:complications; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D009669:Nose Neoplasms / Q000188:drug therapy*; D012878:Skin Neoplasms / Q000188:drug therapy*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068818:Cetuximab